| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.19e-04 | 26 | 17 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 8.82e-04 | 52 | 17 | 2 | GO:0005272 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 4.86e-06 | 41 | 17 | 3 | GO:0061436 | |
| GeneOntologyBiologicalProcess | skin development | 2.08e-04 | 373 | 17 | 4 | GO:0043588 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 3.20e-04 | 166 | 17 | 3 | GO:0098773 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.96e-04 | 36 | 17 | 2 | GO:0086010 | |
| GeneOntologyBiologicalProcess | epidermis development | 4.65e-04 | 461 | 17 | 4 | GO:0008544 | |
| GeneOntologyCellularComponent | keratohyalin granule | 6.22e-06 | 5 | 17 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | cornified envelope | 2.26e-05 | 69 | 17 | 3 | GO:0001533 | |
| MousePheno | abnormal capillary morphology | 6.00e-05 | 93 | 12 | 3 | MP:0003658 | |
| Domain | S100_CABP | 2.39e-04 | 27 | 16 | 2 | PS00303 | |
| Domain | S_100 | 2.39e-04 | 27 | 16 | 2 | PF01023 | |
| Domain | S_100 | 2.57e-04 | 28 | 16 | 2 | SM01394 | |
| Domain | S100_Ca-bd_sub | 2.57e-04 | 28 | 16 | 2 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 2.57e-04 | 28 | 16 | 2 | IPR001751 | |
| Domain | Ion_trans_dom | 4.19e-03 | 114 | 16 | 2 | IPR005821 | |
| Domain | Ion_trans | 4.19e-03 | 114 | 16 | 2 | PF00520 | |
| Domain | EF_Hand_1_Ca_BS | 9.61e-03 | 175 | 16 | 2 | IPR018247 | |
| Domain | EF_HAND_1 | 1.29e-02 | 204 | 16 | 2 | PS00018 | |
| Domain | EF_HAND_2 | 1.63e-02 | 231 | 16 | 2 | PS50222 | |
| Domain | EF_hand_dom | 1.64e-02 | 232 | 16 | 2 | IPR002048 | |
| Domain | - | 2.05e-02 | 261 | 16 | 2 | 1.10.238.10 | |
| Domain | - | 2.39e-02 | 283 | 16 | 2 | 1.10.10.60 | |
| Domain | EF-hand-dom_pair | 2.45e-02 | 287 | 16 | 2 | IPR011992 | |
| Domain | Homeodomain-like | 3.21e-02 | 332 | 16 | 2 | IPR009057 | |
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 6.74e-07 | 3 | 17 | 2 | 23403047 | |
| Pubmed | 3.97e-06 | 64 | 17 | 3 | 36636478 | ||
| Pubmed | 2.69e-05 | 16 | 17 | 2 | 31823782 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 4.70e-05 | 21 | 17 | 2 | 19601998 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 4.92e-05 | 432 | 17 | 4 | 23455922 | |
| Pubmed | Hedgehog signalling controls sinoatrial node development and atrioventricular cushion formation. | 6.17e-05 | 24 | 17 | 2 | 34062094 | |
| Pubmed | 6.43e-05 | 162 | 17 | 3 | 25796446 | ||
| Pubmed | Cullin-3-KCTD10-mediated CEP97 degradation promotes primary cilium formation. | 7.84e-05 | 27 | 17 | 2 | 30404837 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 9.38e-05 | 184 | 17 | 3 | 32908313 | |
| Pubmed | 9.70e-05 | 30 | 17 | 2 | 34905516 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.31e-04 | 1082 | 17 | 5 | 38697112 | |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 2.00e-04 | 238 | 17 | 3 | 35864588 | |
| Pubmed | 2.10e-04 | 44 | 17 | 2 | 31273033 | ||
| Pubmed | 2.18e-04 | 245 | 17 | 3 | 35652658 | ||
| Pubmed | 2.60e-04 | 260 | 17 | 3 | 36199071 | ||
| Pubmed | 14-3-3ζ negatively regulates mitochondrial biogenesis in GBM residual cells. | 2.61e-04 | 49 | 17 | 2 | 34825085 | |
| Pubmed | 3.17e-04 | 54 | 17 | 2 | 35474131 | ||
| Pubmed | 3.41e-04 | 56 | 17 | 2 | 37059927 | ||
| Pubmed | 4.11e-04 | 304 | 17 | 3 | 32235678 | ||
| Pubmed | 4.18e-04 | 62 | 17 | 2 | 26644517 | ||
| Pubmed | 4.59e-04 | 65 | 17 | 2 | 32120844 | ||
| Pubmed | SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein. | 4.74e-04 | 66 | 17 | 2 | 36095012 | |
| Pubmed | 4.76e-04 | 1429 | 17 | 5 | 35140242 | ||
| Pubmed | Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma. | 4.88e-04 | 67 | 17 | 2 | 29863498 | |
| Interaction | RAB3IP interactions | 7.83e-05 | 115 | 15 | 3 | int:RAB3IP | |
| Interaction | DPRX interactions | 7.86e-05 | 18 | 15 | 2 | int:DPRX | |
| Interaction | ARG1 interactions | 1.69e-04 | 149 | 15 | 3 | int:ARG1 | |
| Interaction | YWHAE interactions | 1.78e-04 | 1256 | 15 | 6 | int:YWHAE | |
| Interaction | INSYN1 interactions | 2.45e-04 | 169 | 15 | 3 | int:INSYN1 | |
| Interaction | DNAAF8 interactions | 2.53e-04 | 32 | 15 | 2 | int:DNAAF8 | |
| Interaction | PI4KAP1 interactions | 3.03e-04 | 35 | 15 | 2 | int:PI4KAP1 | |
| Interaction | CYLD interactions | 3.07e-04 | 868 | 15 | 5 | int:CYLD | |
| Interaction | CCNC interactions | 3.35e-04 | 188 | 15 | 3 | int:CCNC | |
| Interaction | KLF5 interactions | 3.73e-04 | 195 | 15 | 3 | int:KLF5 | |
| Interaction | USP20 interactions | 4.37e-04 | 206 | 15 | 3 | int:USP20 | |
| Interaction | PRSS16 interactions | 4.80e-04 | 44 | 15 | 2 | int:PRSS16 | |
| Interaction | OAZ3 interactions | 5.03e-04 | 45 | 15 | 2 | int:OAZ3 | |
| Interaction | CA10 interactions | 5.25e-04 | 46 | 15 | 2 | int:CA10 | |
| Cytoband | 22q13.1 | 4.52e-04 | 85 | 17 | 2 | 22q13.1 | |
| Cytoband | 1q21.3 | 8.54e-04 | 117 | 17 | 2 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 6.52e-03 | 330 | 17 | 2 | chr22q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 9.63e-03 | 404 | 17 | 2 | chr1q21 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 3.59e-06 | 7 | 8 | 2 | 1350 | |
| GeneFamily | EF-hand domain containing | 3.90e-03 | 219 | 8 | 2 | 863 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 142 | 17 | 3 | 94e277f038f4006d99ff50222b0f5cf89bc3d46d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.18e-05 | 181 | 17 | 3 | a8e9ea73c24109a5d4d28bc0577cc869ad932a4d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.68e-05 | 188 | 17 | 3 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.75e-05 | 189 | 17 | 3 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.75e-05 | 189 | 17 | 3 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.83e-05 | 190 | 17 | 3 | 6b101359f397020a21e2bfd15851cb48e71f4502 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.54e-05 | 199 | 17 | 3 | 6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Ctps_(Ctps)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.28e-04 | 90 | 17 | 2 | 4d75217fd6b376bfda3300962cbe4875b31ffdaf | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-3|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.01e-03 | 125 | 17 | 2 | 5f90de494b53ecce6455034f3ed5dccdbb2c29ca | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.10e-03 | 130 | 17 | 2 | 04ad0542210e7a8c8d4d9d0bfd83de2629bc3176 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-03 | 134 | 17 | 2 | 3dd4b5eddc94c1d49ab23b287ee234db3a55331b | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.21e-03 | 137 | 17 | 2 | ca8fdbe66a854e6283b22179ec9359ea9e86cd8e | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.21e-03 | 137 | 17 | 2 | b03f19b233c1c809f2cd2b4a7642eeaf254a6289 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.25e-03 | 139 | 17 | 2 | 789edd3c98e7c5c1cc402c780fded9a9dfd1dfb8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-03 | 145 | 17 | 2 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-2|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.36e-03 | 145 | 17 | 2 | f9aa7f2401e26f1e8cec1112a71c16e1c2784893 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.42e-03 | 148 | 17 | 2 | d60f93311cfa718d026a0dbf61771bbbcbb79146 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.42e-03 | 148 | 17 | 2 | 44128692824ca419fface0af41099c17135933ce | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-03 | 149 | 17 | 2 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-03 | 150 | 17 | 2 | b30f52b94ce772632a1f2f5e0837db876cf92651 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-03 | 150 | 17 | 2 | 05b9a9cbc5a95cdaf45d5f173e132acd4da9aa8a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-03 | 153 | 17 | 2 | 79c4f4ccdc8249c8461075c73491bc3b2d13344a | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-03 | 154 | 17 | 2 | 0066b2b8cfc74603e97f271ef5efc7ec512110dc | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-03 | 159 | 17 | 2 | e967b557fe6ae4879d36f62c0297cbf6a2ad1ce9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-03 | 159 | 17 | 2 | 50d951cf27a571c0c5002003c16fbc370fa17eb1 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-03 | 159 | 17 | 2 | 9db971130509c62d439e0cab16588a4d994d7aa0 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-03 | 159 | 17 | 2 | 24f87c666eff10c1844c900ffd7ad49fa9f80481 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-03 | 161 | 17 | 2 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-03 | 161 | 17 | 2 | 4f25eeabb841b0b9204cdd4e71d5e131e7868184 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-03 | 162 | 17 | 2 | e73c644ce1db34f1d390878954e86fa0b3a455a1 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.71e-03 | 163 | 17 | 2 | ec8336b68c8369e27d507c04c827be07bb48a7f6 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.71e-03 | 163 | 17 | 2 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-03 | 164 | 17 | 2 | 35c673380f75cb4bfe080089bc723c4373bcc7a5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-03 | 164 | 17 | 2 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-03 | 165 | 17 | 2 | c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-03 | 165 | 17 | 2 | 4cdd80580d5638fd649280ba3893251c2f898f3f | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.77e-03 | 166 | 17 | 2 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-03 | 167 | 17 | 2 | 6c2dade24a88af04b2c90a7e4f8dd7ccea9e94d1 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-03 | 169 | 17 | 2 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | NS-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.86e-03 | 170 | 17 | 2 | f6a0162bb690dbc19ff1cec64cb933744ad3b496 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-03 | 170 | 17 | 2 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-03 | 171 | 17 | 2 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-03 | 172 | 17 | 2 | de4961f4037c439d3e0ec706a257b0ec17f4d5be | |
| ToppCell | Frontal_cortex-Macroglia|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.92e-03 | 173 | 17 | 2 | ac70145e093ef0df43811e7c67a865ccdd45a5e3 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-03 | 173 | 17 | 2 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 1.92e-03 | 173 | 17 | 2 | 38f88f5bbf92a3bf5109bc4782cd071b7cb1ca34 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-03 | 174 | 17 | 2 | 64d13a7a9757e85f4f4af876c687dd18a7efa01a | |
| ToppCell | Substantia_nigra-Macroglia|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.95e-03 | 174 | 17 | 2 | 7e7f7ca9a413ec255e54621800a279c771b9e6b7 | |
| ToppCell | Posterior_cortex-Macroglia|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 175 | 17 | 2 | 8bc7a3856d04692989b2a1675ea6d9392261d55a | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.97e-03 | 175 | 17 | 2 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-03 | 176 | 17 | 2 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-03 | 176 | 17 | 2 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-03 | 178 | 17 | 2 | fb8f8d95f6b08378fb42c4076ee040276faa296f | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-03 | 178 | 17 | 2 | b89c4d015b44bf538aa39969ef8778877c8023f1 | |
| ToppCell | Entopeduncular-Macroglia|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.06e-03 | 179 | 17 | 2 | f61974710a60aa0618fdb30d864fb9bc7c05ef21 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 2.06e-03 | 179 | 17 | 2 | 4e0cf069bc47328eda753a4edc7e89b8915d52bb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-03 | 180 | 17 | 2 | d1c52aeceb3627e3c5fb6cc3af77e0400f9380ab | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-03 | 182 | 17 | 2 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-03 | 182 | 17 | 2 | d524ad5cf00f05ee27c9db2ffa2d4e30a1e2e21a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-03 | 183 | 17 | 2 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 183 | 17 | 2 | ecac1cfaff7553a60305b34d6cede6973ffb5430 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 183 | 17 | 2 | 1614704fe0d8cd4c54c49f93f0cefb790ca897c7 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 183 | 17 | 2 | f6ebfd7f61e912f92bd07313cc213a171747ac03 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-03 | 183 | 17 | 2 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-03 | 184 | 17 | 2 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-03 | 184 | 17 | 2 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-03 | 184 | 17 | 2 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-03 | 185 | 17 | 2 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.20e-03 | 185 | 17 | 2 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-03 | 185 | 17 | 2 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-03 | 185 | 17 | 2 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-03 | 185 | 17 | 2 | de353368f4f6a7a0a66e391d586879876fbe2734 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-03 | 185 | 17 | 2 | 60206c7322b4ddb2010040aac70561df842c9843 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-03 | 185 | 17 | 2 | 7460387f48f33674330bd53b759681b264228f5a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-03 | 186 | 17 | 2 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.22e-03 | 186 | 17 | 2 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-03 | 186 | 17 | 2 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-03 | 186 | 17 | 2 | d57c40b3fe5cfc87e771df76533d9a3e94678b04 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-03 | 187 | 17 | 2 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.24e-03 | 187 | 17 | 2 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-03 | 187 | 17 | 2 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-03 | 187 | 17 | 2 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.24e-03 | 187 | 17 | 2 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-03 | 188 | 17 | 2 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-03 | 188 | 17 | 2 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-03 | 188 | 17 | 2 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.27e-03 | 188 | 17 | 2 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 189 | 17 | 2 | 16a4c92dd7a0d60f3691bd3130a091a9a54730f1 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-03 | 189 | 17 | 2 | da014519d6eb21bc2dc2ed65eafe638b42a068ed | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-03 | 189 | 17 | 2 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 2.29e-03 | 189 | 17 | 2 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.31e-03 | 190 | 17 | 2 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.31e-03 | 190 | 17 | 2 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.31e-03 | 190 | 17 | 2 | 396b7225c2430db3dc55a3d0db70239b71987229 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.31e-03 | 190 | 17 | 2 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.31e-03 | 190 | 17 | 2 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-03 | 191 | 17 | 2 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.34e-03 | 191 | 17 | 2 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | background-Cholangiocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.34e-03 | 191 | 17 | 2 | 99aa8d685767a72bef9f05e7cc8913126a048c39 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-03 | 192 | 17 | 2 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; PC3; HT_HG-U133A | 8.58e-06 | 194 | 16 | 4 | 4657_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 9.12e-06 | 197 | 16 | 4 | 4751_DN | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; PC3; HT_HG-U133A | 9.30e-06 | 198 | 16 | 4 | 6641_DN | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; HL60; HT_HG-U133A | 9.30e-06 | 198 | 16 | 4 | 2436_UP | |
| Drug | HCNs | 8.73e-05 | 20 | 16 | 2 | CID006857665 | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A | 3.05e-04 | 192 | 16 | 3 | 6639_DN | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 3.10e-04 | 193 | 16 | 3 | 6964_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 3.10e-04 | 193 | 16 | 3 | 2283_UP | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 6739_DN | |
| Drug | arachidonyl trifluoromethyl ketone; Up 200; 10uM; MCF7; HG-U133A | 3.19e-04 | 195 | 16 | 3 | 327_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 4326_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; PC3; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 6754_DN | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 4960_UP | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 7055_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 7552_UP | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 7432_UP | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; PC3; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 7317_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HG-U133A | 3.24e-04 | 196 | 16 | 3 | 1958_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 6775_DN | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 3.29e-04 | 197 | 16 | 3 | 205_UP | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5773_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 4134_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; PC3; HG-U133A | 3.29e-04 | 197 | 16 | 3 | 1925_UP | |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5747_UP | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 1496_DN | |
| Drug | Primidone [125-33-7]; Up 200; 18.4uM; HL60; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 3065_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 4732_DN | |
| Drug | Tobramycin [32986-56-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 4081_DN | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 7428_UP | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 2316_DN | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 2891_UP | |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 4062_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 6332_UP | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; HL60; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 2432_UP | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 3897_DN | |
| Drug | Ribavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 6521_UP | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 4774_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 4562_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 4634_DN | |
| Drug | Arecoline hydrobromide [300-08-3]; Down 200; 17uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 6322_DN | |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 6686_UP | |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 4957_UP | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 6033_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 4379_DN | |
| Drug | Noscapine [128-62-1]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 5851_UP | |
| Disease | peeling skin syndrome (is_implicated_in) | 4.68e-06 | 6 | 17 | 2 | DOID:0060283 (is_implicated_in) | |
| Disease | resting heart rate | 3.28e-03 | 149 | 17 | 2 | EFO_0004351 | |
| Disease | cardioembolic stroke | 4.24e-03 | 170 | 17 | 2 | EFO_1001976 | |
| Disease | coffee consumption measurement | 4.84e-03 | 182 | 17 | 2 | EFO_0006781 | |
| Disease | endometriosis | 9.08e-03 | 252 | 17 | 2 | EFO_0001065 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGFHHSEEGTSSSGS | 566 | Q5SW79 | |
| SHSHSGSSSGGSKHS | 576 | O60583 | |
| SSSSHSGNSGSHSGS | 136 | Q15517 | |
| SGNSGSHSGSSSSHS | 141 | Q15517 | |
| PSSGGHTSHSGDNSS | 231 | O00470 | |
| GGGSSSRPASHSHAH | 1841 | Q9Y618 | |
| HSGHGQSTQTGSRTS | 1326 | Q5D862 | |
| SGGSHTHSGHTHGQS | 1511 | Q5D862 | |
| TGDTSGHSQSGHGQS | 1851 | Q5D862 | |
| GHSQSGHGQSTQSGS | 1856 | Q5D862 | |
| SSTSSAGSGGSPDHH | 206 | A6NKD9 | |
| HGSGSGQSSGFSQHK | 221 | Q86YZ3 | |
| SPSHVRHGSGSGHSS | 306 | Q86YZ3 | |
| RHGSGSGHSSSHGQH | 311 | Q86YZ3 | |
| SGHSSSHGQHGSGSS | 316 | Q86YZ3 | |
| SGSGHSSSQGQHGST | 366 | Q86YZ3 | |
| QHGSTSGQASSSGQH | 376 | Q86YZ3 | |
| GSSSGHSSTHGQHGS | 601 | Q86YZ3 | |
| HSSTHGQHGSTSGQS | 606 | Q86YZ3 | |
| HGATSGQSSSHGQHG | 626 | Q86YZ3 | |
| GQSSSHGQHGSGSSQ | 631 | Q86YZ3 | |
| HGSSSGHSSSHGQHG | 781 | Q86YZ3 | |
| GHSSSHGQHGSGTSC | 786 | Q86YZ3 | |
| HGSSSGHSSTHGQHG | 1066 | Q86YZ3 | |
| GHSSTHGQHGSTSGQ | 1071 | Q86YZ3 | |
| HGQHGSTSGQSSSCG | 1076 | Q86YZ3 | |
| SGQSSSHGQHGSGSS | 1096 | Q86YZ3 | |
| GLGHSSSHGQHGSGS | 1251 | Q86YZ3 | |
| SSHGQHGSGSGRSSS | 1256 | Q86YZ3 | |
| SSGCTQHGSGSGHSS | 1411 | Q86YZ3 | |
| HGSSSGHSSTHGQHG | 1536 | Q86YZ3 | |
| GHSSTHGQHGSTSGQ | 1541 | Q86YZ3 | |
| HGQHGSTSGQSSSCG | 1546 | Q86YZ3 | |
| SGQSSSHGQHGSGSS | 1566 | Q86YZ3 | |
| GLGHSSSHGQHGSGS | 1721 | Q86YZ3 | |
| SSHGQHGSGSGRSSS | 1726 | Q86YZ3 | |
| EGSSTGQSSSHGQHG | 1796 | Q86YZ3 | |
| GQSSSHGQHGSGSSQ | 1801 | Q86YZ3 | |
| HGSSSGHSSTHGQHG | 2006 | Q86YZ3 | |
| GHSSTHGQHGSASGQ | 2011 | Q86YZ3 | |
| SGQSSSHGQHGSGSS | 2036 | Q86YZ3 | |
| GRHGSGSGHSSSHGQ | 2186 | Q86YZ3 | |
| GSGHSSSHGQHGSGS | 2191 | Q86YZ3 | |
| SSHGQHGSGSGRSSS | 2196 | Q86YZ3 | |
| EGSSTGQSSSHGQHG | 2266 | Q86YZ3 | |
| GQSSSHGQHGSGSSQ | 2271 | Q86YZ3 | |
| HGSSSGHSSTHGQHG | 2476 | Q86YZ3 | |
| GHSSTHGQHGSTSGQ | 2481 | Q86YZ3 | |
| HGQHGSTSGQSSSCG | 2486 | Q86YZ3 | |
| SGQSSSHGQHGSGSS | 2506 | Q86YZ3 | |
| GLGHSSSHGQHGSGS | 2661 | Q86YZ3 | |
| SSHGQHGSGSGRSSS | 2666 | Q86YZ3 | |
| DSGSHSGSDSHSGAS | 211 | Q96N21 | |
| GGTGSGSSHGHLHDS | 111 | Q9Y3Q4 | |
| SHSSGGSTSPGCTHH | 2086 | Q9P0X4 | |
| TSFLSNHGGSSGSTH | 61 | Q00587 | |
| NSSEGSSSGSGHKHS | 126 | Q8TC76 | |
| GDTGSGHSGSGHSTA | 226 | A0A1W2PPM1 | |
| SSLHTHGSTGTAEGG | 11 | Q96SI1 | |
| GSSHGISSHGSCQGT | 1226 | Q502W6 | |
| THSGHGGHGSIFSIS | 186 | Q96AQ2 |